Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Study Information
Alliance Study ID: NCCTG-N057E
NCT Study ID (ClinicalTrials.gov): NCT00404235
Disease or Cancer Type: Melanoma & Skin Cancers
Alliance Study Chair: Svetomir Markovic, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy, such as carboplatin and ABI-007, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This phase II trial is studying the side effects and how well giving carboplatin together with ABI-007 works in treating patients with stage IV melanoma that cannot be removed by surgery.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information